Title |
Genetic Instability in Werner Syndrome
|
Institution |
UNIVERSITY OF WASHINGTON, SEATTLE, WA
|
Principal Investigator |
MONNAT, RAYMOND
|
NCI Program Director |
Paul Okano
|
Cancer Activity |
DNA Chromosome Aberrations
|
Division |
DCB
|
Funded Amount |
$1,355,674
|
Project Dates |
03/07/2000 - 02/28/2009
|
Fiscal Year |
2007
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Aging (100.0%)
Biochemical Epidemiology (5.0%)
Chemotherapy (5.0%)
Chronic Myeloproliferative Disorders (20.0%)
Genetic Testing (50.0%)
Hematology (20.0%)
Neurosciences Research (10.0%)
Orphan Drug Research (5.0%)
|
Brain (10.0%)
Leukemia (20.0%)
Melanoma (15.0%)
Thyroid (15.0%)
|
Research Type |
Cancer Initiation: Alterations in Chromosomes
Cancer Initiation: Oncogenes and Tumor Suppressor Genes
|
Abstract |
DESCRIPTION (provided by applicant): The long term goal of research proposed in this Program Project is to provide a detailed description of the Werner syndrome protein (WRN) functional pathway in human somatic cells, and to determine how a loss of WRN function leads to the cellular and clinical phenotypes of Werner syndrome that include constitutional genetic instability and an elevated risk of cancer. The Werner Syndrome Program Project is an integrated research effort consisting of 4 Projects and 2 Cores that are collectively focused on the following questions: 1. what proteins and DNA substrates constitute the WRN functional pathway in human somatic cells? 2. what are the important physiologic functions of WRN in human somatic cells? 3. how does loss of WRN function lead to genetic instability, selective DNA damage hypersensitivity and cell proliferation defects? 4. what role do WRN polymorphisms and mutations play in promoting the risk or pathogenesis of cancer or other diseases in the general population? Results of the proposed research will delineate normal functions of the WRN protein in human somatic cells, and how the loss of function leads to pathogenesis of the Werner syndrome cellular and clinical phenotypes. Results of the proposed research will also indicate the potential importance of common heritable alterations in WRN expression---polymorphisms in, or loss of one active copy of, the WRN gene--in promoting cancer risk and pathogenesis in the general population. |